News

Deal Announcements

Avitide Secures Venture Capital Equity Funding

Tuesday, June 10, 2014 5:30:00 AM PDT | VentureDeal

Lebanon, New Hampshire -- Biotechnology company Avitide has raised $3.4 million in new equity investment, according to an SEC regulatory filing.

Avitide develops customized biopharmaceutical affinity purification products that help reduce development timelines, program risk and cost of manufacture.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Avitide is backed by a syndicate of venture capital firms.

Email Page | Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

About VentureDeal

Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.

Learn More »

Home
Overview
Service Firms
Tech Entrepreneurs
Venture Investors

Services
Subscribe
Use Cases

FAQ
Terms of Use
Privacy Policy
Contact
Login